Impact of stress-induced diabetes on outcomes in severely burned children.
Abstract | BACKGROUND: STUDY DESIGN: We randomized pediatric patients with massive burns into 2 groups, patients receiving sliding scale insulin to lower blood glucose levels (n = 145) and those receiving no insulin (n = 98), to determine the differences in morbidity and mortality. Patients 0 to 18 years old with burns covering ≥ 30% of the total body surface area and not randomized to receive anabolic agents were included in this study. End points included glucose levels, infections, resting energy expenditure, lean body mass, bone mineral content, fat mass, muscle strength, and serum inflammatory cytokines, hormones, and liver enzymes. RESULTS: Maximal glucose levels occurred within 6 days of burn injury. Blood glucose levels were age dependent, with older children requiring more insulin (p < 0.05). Daily maximum and daily minimum, but not 6 am, glucose levels were significantly different based on treatment group (p < 0.05). Insulin significantly increased resting energy expenditure and improved bone mineral content (p < 0.05). Each additional wound infection increased incidence of hyperglycemia (p = 0.004). There was no mortality in patients not receiving insulin, only in patients who received insulin (p < 0.004). Muscle strength was increased in patients receiving insulin (p < 0.05). CONCLUSIONS:
Burn-induced hyperglycemia develops in a subset of severely burned children. Length of stay was reduced in the no insulin group, and there were no deaths in this group. Administration of insulin positively impacted bone mineral content and muscle strength, but increased resting energy expenditure, hypoglycemic episodes, and mortality. New glucose-lowering strategies might be needed.
|
Authors | Celeste C Finnerty, Arham Ali, Josef McLean, Nicole Benjamin, Robert P Clayton, Clark R Andersen, Ronald P Mlcak, Oscar E Suman, Walter Meyer, David N Herndon |
Journal | Journal of the American College of Surgeons
(J Am Coll Surg)
Vol. 218
Issue 4
Pg. 783-95
(Apr 2014)
ISSN: 1879-1190 [Electronic] United States |
PMID | 24655871
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2014 American College of Surgeons. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Blood Glucose
- Cytokines
- Hypoglycemic Agents
- Insulin
|
Topics |
- Adolescent
- Age Factors
- Biomarkers
(blood)
- Blood Glucose
(metabolism)
- Body Composition
(drug effects)
- Burns
(blood, complications, mortality, therapy)
- Calorimetry, Indirect
- Child
- Child, Preschool
- Cytokines
(blood)
- Energy Metabolism
(drug effects)
- Female
- Humans
- Hyperglycemia
(blood, diagnosis, drug therapy, etiology)
- Hypoglycemic Agents
(pharmacology, therapeutic use)
- Infant
- Infant, Newborn
- Insulin
(pharmacology, therapeutic use)
- Liver
(drug effects, physiology)
- Male
- Models, Statistical
- Muscle Strength
(drug effects)
- Treatment Outcome
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|